Scientific Advisory Board World-renowned experts dedicated to advancing the field of intra-lesional treatments. Their collective knowledge and strategic insights drive our commitment to revolutionize the treatment landscape for skin cancer patients worldwide.
Scientific Advisory Board with
Thought Leaders in the Field
Antoni Ribas MD, PhD
Professor of Medicine, Surgery and Molecular & Medical Pharmacology at UCLA
Georgina Long AO, BSc, PhD, MBBS, FRACP
Co-Medical Director of Melanoma Institute of Australia (MIA)
Ralph R. Weichselbaum MD
Ludwig Professor of Radiation and Cellular Oncology, University of Chicago
